Erratum to: Durvalumab: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-017-0826-x
Published Online: 2017-10-10
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Syed, Yahiya Y.
License valid from 2017-10-01